Financial Disclosure Statement

MSACL 2018 US Abstract Title:
Tumor Tissue Proteomics in the CAP/CLIA Laboratory: A 5-year Update
Maryann Vogelsang
NantOmics

DescriptionY/NSource
Grantsno
SalaryyesNantOmics
Board Memberno
Stockyes NantOmics
Expensesno

IP Royalty: no

Planning to mention or discuss specific products or technology of the company(ies) listed above:

yes